BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SETD2, ENSG00000181555, 29072 AND Prognosis
6 results:

  • 1. Dysregulation of miR-551b-5p and
    Dong A; Gao M; Zheng X; Ruan X
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1400-1409. PubMed ID: 37073141
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
    Zhang C; Li Y; Qian J; Zhu Z; Huang C; He Z; Zhou L; Gong Y
    Front Immunol; 2022; 13():1020729. PubMed ID: 36479115
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
    Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
    Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
    Callens C; Driouch K; Boulai A; Tariq Z; Comte A; Berger F; Belin L; Bièche I; Servois V; Legoix P; Bernard V; Baulande S; Chemlali W; Bidard FC; Fourchotte V; Salomon AV; Brain E; Lidereau R; Bachelot T; Saghatchian M; Campone M; Giacchetti S; Zafrani BS; Cottu P
    Genome Med; 2021 Mar; 13(1):44. PubMed ID: 33722295
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
    Morcillo-Garcia S; Noblejas-Lopez MDM; Nieto-Jimenez C; Perez-Peña J; Nuncia-Cantarero M; Győrffy B; Amir E; Pandiella A; Galan-Moya EM; Ocana A
    PLoS One; 2019; 14(4):e0209134. PubMed ID: 30990809
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Loss of setd2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
    Liu L; Guo R; Zhang X; Liang Y; Kong F; Wang J; Xu Z
    Biosci Trends; 2017 May; 11(2):214-220. PubMed ID: 28260718
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.